Cargando…

The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells

Alzheimer’s disease (AD) is a type of dementia that affects memory, thinking and behavior. Symptoms eventually become severe enough to interfere with daily tasks. Understanding the etiology and pathogenesis of AD is necessary for the development of strategies for AD prevention and/or treatment, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Karapetyan, Gohar, Fereshetyan, Katarine, Harutyunyan, Hayk, Yenkoyan, Konstantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596457/
https://www.ncbi.nlm.nih.gov/pubmed/36284177
http://dx.doi.org/10.1038/s41598-022-22761-5
_version_ 1784815874912288768
author Karapetyan, Gohar
Fereshetyan, Katarine
Harutyunyan, Hayk
Yenkoyan, Konstantin
author_facet Karapetyan, Gohar
Fereshetyan, Katarine
Harutyunyan, Hayk
Yenkoyan, Konstantin
author_sort Karapetyan, Gohar
collection PubMed
description Alzheimer’s disease (AD) is a type of dementia that affects memory, thinking and behavior. Symptoms eventually become severe enough to interfere with daily tasks. Understanding the etiology and pathogenesis of AD is necessary for the development of strategies for AD prevention and/or treatment, and modeling of this pathology is an important step in achieving this goal. β-amyloid peptide (Aβ) injection is a widely used approach for modeling AD. Nevertheless, it has been reported that the model constructed by injection of Aβ in combination with a prooxidant cocktail (ferrous sulfate, Aβ, and buthionine sulfoximine (BSO) (FAB)) best reflects the natural development of this disease. The relationship between oxidative stress and Aβ deposition and their respective roles in Aβ-induced pathology in different animal models of AD have been thoroughly investigated. In the current paper, we compared the effects of Aβ 1-42 alone with that of Aβ-associated oxidative stress induced by the FAB cocktail on the neurodegeneration of hippocampal cells in vitro. We constructed a FAB-induced AD model using rat primary hippocampal cells and analyzed the contribution of each compound. The study mainly focused on the prooxidant aspects of AD pathogenesis. Moreover, cellular bioenergetics was assessed and routine metabolic tests were performed to determine the usefulness of this model. The data clearly show that aggregated Aβ1-42 alone is significantly less toxic to hippocampal cells. Aggregated Aβ damages neurons, and glial cells proliferate to remove Aβ from the hippocampus. External prooxidant agents (Fe(2+)) or inhibition of internal antioxidant defense by BSO has more toxic effects on hippocampal cells than aggregated Aβ alone. Moreover, hippocampal cells fight against Aβ-induced damage more effectively than against oxidative damage. However, the combination of Aβ with external oxidative damage and inhibition of internal antioxidant defense is even more toxic, impairs cellular defense systems, and may mimic the late phase of AD-associated cell damage. Our findings strongly indicate a critical role for the combination of Aβ and oxidative stress in the development of neurodegeneration in vitro.
format Online
Article
Text
id pubmed-9596457
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95964572022-10-27 The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells Karapetyan, Gohar Fereshetyan, Katarine Harutyunyan, Hayk Yenkoyan, Konstantin Sci Rep Article Alzheimer’s disease (AD) is a type of dementia that affects memory, thinking and behavior. Symptoms eventually become severe enough to interfere with daily tasks. Understanding the etiology and pathogenesis of AD is necessary for the development of strategies for AD prevention and/or treatment, and modeling of this pathology is an important step in achieving this goal. β-amyloid peptide (Aβ) injection is a widely used approach for modeling AD. Nevertheless, it has been reported that the model constructed by injection of Aβ in combination with a prooxidant cocktail (ferrous sulfate, Aβ, and buthionine sulfoximine (BSO) (FAB)) best reflects the natural development of this disease. The relationship between oxidative stress and Aβ deposition and their respective roles in Aβ-induced pathology in different animal models of AD have been thoroughly investigated. In the current paper, we compared the effects of Aβ 1-42 alone with that of Aβ-associated oxidative stress induced by the FAB cocktail on the neurodegeneration of hippocampal cells in vitro. We constructed a FAB-induced AD model using rat primary hippocampal cells and analyzed the contribution of each compound. The study mainly focused on the prooxidant aspects of AD pathogenesis. Moreover, cellular bioenergetics was assessed and routine metabolic tests were performed to determine the usefulness of this model. The data clearly show that aggregated Aβ1-42 alone is significantly less toxic to hippocampal cells. Aggregated Aβ damages neurons, and glial cells proliferate to remove Aβ from the hippocampus. External prooxidant agents (Fe(2+)) or inhibition of internal antioxidant defense by BSO has more toxic effects on hippocampal cells than aggregated Aβ alone. Moreover, hippocampal cells fight against Aβ-induced damage more effectively than against oxidative damage. However, the combination of Aβ with external oxidative damage and inhibition of internal antioxidant defense is even more toxic, impairs cellular defense systems, and may mimic the late phase of AD-associated cell damage. Our findings strongly indicate a critical role for the combination of Aβ and oxidative stress in the development of neurodegeneration in vitro. Nature Publishing Group UK 2022-10-25 /pmc/articles/PMC9596457/ /pubmed/36284177 http://dx.doi.org/10.1038/s41598-022-22761-5 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Karapetyan, Gohar
Fereshetyan, Katarine
Harutyunyan, Hayk
Yenkoyan, Konstantin
The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
title The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
title_full The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
title_fullStr The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
title_full_unstemmed The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
title_short The synergy of β amyloid 1-42 and oxidative stress in the development of Alzheimer’s disease-like neurodegeneration of hippocampal cells
title_sort synergy of β amyloid 1-42 and oxidative stress in the development of alzheimer’s disease-like neurodegeneration of hippocampal cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596457/
https://www.ncbi.nlm.nih.gov/pubmed/36284177
http://dx.doi.org/10.1038/s41598-022-22761-5
work_keys_str_mv AT karapetyangohar thesynergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells
AT fereshetyankatarine thesynergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells
AT harutyunyanhayk thesynergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells
AT yenkoyankonstantin thesynergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells
AT karapetyangohar synergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells
AT fereshetyankatarine synergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells
AT harutyunyanhayk synergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells
AT yenkoyankonstantin synergyofbamyloid142andoxidativestressinthedevelopmentofalzheimersdiseaselikeneurodegenerationofhippocampalcells